In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Evaluating evidence Ex-Zantac users suing in Delaware’s state courts say Medinilla properly carried out her legal duty to evaluate the legitimacy of the scientific evidence.

The In re Zantac (Ranitidine) Litigation appeal provides the First State's high court a prime opportunity to clarify Delaware law on those two issues and remind trial judges that in most instances ...

GSK has consistently maintained that the expert testimony which claims that an ingredient in the antacid drug Zantac is linked to cancer cannot be relied upon - Delaware's highest court is ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.

Delaware’s top court ruled in GSK’s favor in saying it will review the admissibility of expert evidence in an upcoming trial over possible cancer risks from its Zantac heartburn remedy ...

Delaware’s top court is set to hear an appeal from GSK to throw out lawsuits alleging that the heartburn drug Zantac caused cancer.